Capsigen is an adeno-associated virus (AAV) gene therapy company that engineers viral capsids that can deliver gene payloads to target cells while avoiding other tissues and organs, improving drug efficacy and reducing toxicity. Their platform screens billions of capsid candidates simultaneously and incorporates machine learning and a rational design platform to generate capsids that are optimized for disease-specific delivery.